Keywords
Anesthesiology Case Reports
Cardiology Case Reports
Dentistry Case Reports
Diabetology Case Reports
Gastroenterology Case Reports
Otolaryngology Case Reports
Clinical Imaging and Case Reports, 2026, Volume 20, Issue 1, Pages: 1-13
Real-World Performance, Tolerability And User Acceptance Of A Hypertonic Seawater Nasal Spray Containing Hyaluronic Acid And Dexpanthenol For Nasal Mucosal Hydration And Symptom Relief: A Multicentre Post-Market User Survey
Correspondence to Author: Sentiljana Gumeni¹, Konstantinos Alevizopoulos¹*.
Gerolymatos International SA, Asklipiou 8, Kryoneri 14568, Greece
DOI: 10.52338/cicasrep.2026.6328
Abstract:
Nasal mucosal dryness and nasal obstruction are frequent complaints in allergic and infectious rhinitis, during the common cold and influenza, following endonasal surgery, in low-humidity or air-conditioned environments, and in rhinitis sicca, including medication-induced mucosal drying. Seawater-based nasal sprays are widely used as non-pharmacological means to enhance mucosal hydration and support mucociliary clearance. This study aimed to characterize symptom evolution, onset of relief, tolerability, device performance and user acceptance of a hypertonic seawater nasal spray containing hyaluronic acid and dexpanthenol (herein HSHD) under routine conditions of use in 252 subjects. In the 160 participants with complete scores, the Composite Total Symptom Score (CTSS) decreased from 30.2 ± 13.6 to 11.9 ± 9.6 (mean reduction 18.3 points, 60.5%; p < 0.001). Improvement after the use of HSHD was reported within 30 minutes of administration by 189/239 patients (79.1%) and within the first three days of use by 220/237 (92.8%). Adverse events were reported by 8/252 participants (3.2%), all local (nasal irritation, epistaxis and stinging sensation). All respondents rated the device easy to use (237/237, 100%) and 97.9% (230/235) would recommend or repurchase it; no device malfunctions were reported. Overall, these data support the performance, safety and usability of HSHD under routine conditions of use.
Keywords: Seawater nasal spray; Nasal dryness; Rhinitis sicca; Nasal congestion; Real-world evidence; Hyaluronic acid; Dexpanthenol.
Citation:
Dr.Konstantinos Alevizopoulos, Real-World Performance, Tolerability And User Acceptance Of A Hypertonic Seawater Nasal Spray Containing Hyaluronic Acid And Dexpanthenol For Nasal Mucosal Hydration And Symptom Relief: A Multicentre Post-Market User Survey. Clinical Imaging and Case Reports 2026.
Journal Info
- Journal Name: Clinical Imaging and Case Reports
- Impact Factor: 2.709**
- ISSN: 2770-9205
- DOI: 10.52338/cicasrep
- Short Name: CICASREP
- Acceptance rate: 55%
- Volume: 2025
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility